Amanda Wagner Gee is an associate director at FasterCures, a center of the Milken Institute, working on projects related to health equity and diversity in clinical trials and community-based research infrastructure. Her expertise is in areas related to clinical and preclinical research design and conduct. Prior to joining FasterCures, she worked at the National Academies on the Forum for Drug Discovery, Development, and Translation on projects related to the clinical trials enterprise, diversity and inclusion in clinical trials, real-world data and real-world evidence, and patient- and participant-engagement. She began her career as a research scientist working on drug discovery with the Harvard Stem Cell Institute and the National Center for Advancing Translational Sciences at the National Institutes of Health. She received her master’s degree in cell biology from Duke University.